Apollo Cancer Center introduces blood test for early diagnosis of breast cancer

The first of its kind, a blood test can detect breast cancer at a very early stage. It was launched in India on Wednesday and made available by Datar Cancer Genetics, a private company partnered with the Apollo hospital group. According to reports, the blood test can help detect early-stage breast cancer for those over the age of 40. This is an innovative diagnostic technique that has been used by 15 countries, including several countries in Europe.

According to the team of experts, this blood test has an accuracy of 99 percent. “As cancer cases continue to be reported in India, the cost of care or treatment for treating patients is a major cause for concern. The only way (treatment costs) can be reduced by identifying patients at an early stage If women are detected early in breast cancer, they can be treated effectively, leading to an increase in life expectancy and a reduction in treatment problems, so I think it will have a significant impact,” said Dr. Chirantan Bose, Director of Patient Care, Datar Cancer Genetics Ltd.

READ | How do drugs know where to go in the body and cure the ailment?

The blood test was approved by the World Health Organization (WHO) and the US Food and Drug Administration last November, after seeing its benefits in the largest clinical trials. The doctor said: “It offers the largest clinical trials ever submitted to WHO. This particular trial collected data on breast cancer that screened more than 8,000 asymptomatic women and followed them over a 12-month period. on our website.”

The study found that stage 0 and stage 1 breast cancers were detected with 99 percent accuracy. The test, which is branded as EasyCheck Breast, costs Rs 6,000. It was approved by the U.S. Food and Drug Administration last November and is indicated as an annual test for healthy women over the age of 40 who may not have any symptoms. The technology claims to have nearly 99 percent sensitivity, meaning it has less than 1 percent false positive reports, with over 88 percent specificity, meaning there is a chance of false negativity in about 22 percent of cases, though.

READ | How simpler, faster approaches to breast cancer can help treat more patients, improve the experience

“It’s not a replacement for mammograms, but women who test positive for breast cancer using the new technology can undergo conventional screening exams and have a biopsy right away and plan their treatment for cancer,” said Dr. Ramesh Sarin, a senior surgeon oncologist at the Apollo Hospital in Delhi. The doctor further suggests that if a woman tests negative, she should also undergo other screening tests to completely rule out cancer.

“This is the first time in India that Apollo Centers in partnership with Datar Cancer Genetics is bringing this non-invasive blood test that allows it to detect early stage breast cancer in asymptomatic individuals with high accuracy. This will help us save and preserve lives quality of life,” says Sangeetha Reddy, JMD, Apollo Hospitals.

Leave a Comment

Your email address will not be published.